OVA Conjugated Ofloxacin (OFX)

  • Catalog number
    CPK753Ge21-100ug
  • Price
    Please ask
  • Size
    100ug
  • Description
    Recombinant Pan-species Ofloxacin expressed in: E.coli
  • Specifications
    Host species: Pan-species (General); Expression system: E.coli; Expression region: Inquire; Purity: > 90%; Endotoxin level:
  • Additional_information
    Uniprot ID: Inquire; Buffer composition: PBS, pH 7.4.; Form: Freeze-dried powder; Predicted Molecular Mass (KD): 228.1Da; Isoelectric Point: Inquire
  • Storage_and_shipping
    Shipped on ice packs. Upon receipt keep at 2-8 °C for up to 1 month. For long term storage prepare working aliquots and keep frozen at -20 or -80 °C. Avoid repeated freezing and thawing.
  • Notes
    Research Use Only.
  • Gene
    Ovalbumin (abbreviated OVA) is the main protein found in egg white, making up 60-65% of the total protein. Ovalbumin displays sequence and three-dimensional homology to the serpin superfamily, but unlike most serpins it is not a serine protease inhibitor. The function of ovalbumin is unknown, although it is presumed to be a storage protein. OVA is also the best characterized and the first antigen proteins used as a transgene to make transgenic mice. Many different transgenic mouse models have systemic OVA expression driven by the ubiquitously expressed b-actin promoter or tissue-specific OVA expression with insulin promoter to drive the transgene expression, for studying type I diabetes, or in different isoforms, secreted or cell-membrane associated, and more recently as inducible transgene models. These C57BL/6 mice, BALB/c mice models are well characterized, and have contributed to our understanding of immunogenicity and tolerance by the OVA model.
  • Gene target
    OVA   Conjugated   Ofloxacin   OFX  
  • Short name
    OVA Conjugated Ofloxacin (OFX)
  • Technique
    antibody Conjugates
  • Alternative name
    OVA coupled Ofloxacin (OFX)
MeSH Data
  • Name
  • Concept
    Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
  • Tree numbers
    • E05.393.220
  • Qualifiers
    drug effects, methods, radiation effects
Similar products
Filters
Contact
Chat with gentaur.com employee